Release Date: 24/06/09 17:54 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 209.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%